Healthcare Industry News:  CardioWest 

Devices Cardiology

 News Release - October 10, 2007

University of Wisconsin, One of Most Successful U.S. Heart Transplant Programs, Begins Certification Training on CardioWest Artificial Heart

Transplant Leader Will Be 26th Hospital to Provide Temporary Artificial Heart That Has Highest Bridge to Transplant Rate

TUCSON, Ariz.--(HSMN NewsFeed)--On Sept. 10 and 11, the University of Wisconsin (UW) heart transplant team, including Niloo M. Edwards, M.D., chairman of cardiothoracic surgery and director of cardiac transplantation, and Takushi Kohmoto, M.D., director of the mechanical assist device program, received the first of four phases of certification training on the CardioWest(TM) temporary Total Artificial Heart (TAH-t) at University Medical Center in Tucson.

The heart transplant program at UW is one of the more active in the United States, with more than 560 heart transplants performed during its history. According to statistics from the United Network for Organ Sharing, heart transplant survival rates at UW are some of the highest in the country. While the national patient survival rate for three years post-transplant is 79.7 percent, the three-year survival rate at UW is 86.67 percent.

Today there are 22 CardioWest artificial heart certified centers, 11 in the U.S. and 11 in Europe. UW is the 26th hospital in the world to receive the first phase of certification training.

The CardioWest artificial heart is the only FDA and CE approved temporary artificial heart in the world. Originally designed as a permanent replacement heart, the CardioWest artificial heart is currently approved as a bridge to transplant for patients dying from end stage biventricular failure. Their survival depends on receiving a donor heart, or an artificial heart as a bridge to human heart transplant.

The pivotal clinical study of the CardioWest artificial heart published in the New England Journal of Medicine (NEJM 2004; 351: 859-867) showed that 79 percent of patients receiving the artificial heart survived to transplant, the highest survival rate for any heart device in the world.


Source: SynCardia Systems

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.